Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan triple therapy versus conventional triple therapy for Helicobacter pylori eradication
PACTR202606774127532Unknown
- Sponsor
- Tropical Medicine Department, Faculty of Medicine, Alexandria University
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vonoprazan and rabeprazole in Helicobacter pylori infection (2 arms), sponsored by Tropical Medicine Department, Faculty of Medicine, Alexandria University. Primary endpoint: Successful H. pylori eradication. Status: unknown.
02
Drugs
vonoprazanrabeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on PACTR202606774127532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202606774127532.